BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1241 related articles for article (PubMed ID: 34670584)

  • 1. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
    Zheng H; Liu H; Ge Y; Wang X
    Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblast-related gene signatures predict survival and drug response in patients with colorectal cancer.
    Zhang L; Xu C; Wang SH; Ge QW; Wang XW; Xiao P; Yao QH
    Front Genet; 2022; 13():1054152. PubMed ID: 36506313
    [No Abstract]   [Full Text] [Related]  

  • 3. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer.
    Zheng H; Liu H; Li H; Dou W; Wang X
    Front Mol Biosci; 2021; 8():744677. PubMed ID: 34692770
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of prognostic cancer-associated fibroblast markers in luminal breast cancer using weighted gene co-expression network analysis.
    Xu A; Xu XN; Luo Z; Huang X; Gong RQ; Fu DY
    Front Oncol; 2023; 13():1191660. PubMed ID: 37207166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
    Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
    J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
    Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
    Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma.
    Liu Y; Jian J; Zhang Y; Wang L; Liu X; Chen Z
    Front Oncol; 2023; 13():1170893. PubMed ID: 37124542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
    Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
    Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influential upregulation of KCNE4: Propelling cancer associated fibroblasts-driven colorectal cancer progression.
    Zhang Z; Liu S; Wang Z; Wang S; Jiang L; Wang X; Li J; Shen L
    Cancer Cell Int; 2024 Mar; 24(1):103. PubMed ID: 38462626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
    Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
    Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of Single-Cell and Bulk RNA-seq Data to Identify the Cancer-Associated Fibroblast Subtypes and Risk Model in Glioma.
    Yan X; Gao X; Dong J; Wang F; Jiang X; Hu X; Zhang J; Wang N; Xu L; Liu Z; Hu S; Zhao H
    Biochem Genet; 2024 Mar; ():. PubMed ID: 38536568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAF signature predicts the prognosis of colorectal cancer patients: A retrospective study based on bulk RNA sequencing and single-cell RNA sequencing data.
    Liang C; Ji D; Qin F; Chen G
    Medicine (Baltimore); 2023 Mar; 102(10):e33149. PubMed ID: 36897717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
    Liang X; Cheng Z; Chen X; Li J
    Front Genet; 2022; 13():955424. PubMed ID: 36046241
    [No Abstract]   [Full Text] [Related]  

  • 16. A WGCNA-based cancer-associated fibroblast risk signature in colorectal cancer for prognosis and immunotherapy response.
    Lv Y; Hu J; Zheng W; Shan L; Bai B; Zhu H; Dai S
    Transl Cancer Res; 2023 Sep; 12(9):2256-2275. PubMed ID: 37859738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer.
    Wu ZZ; Wei YJ; Li T; Zheng J; Liu YF; Han M
    World J Clin Cases; 2024 Feb; 12(4):700-720. PubMed ID: 38322675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated single-cell and bulk RNA sequencing analyses reveal a prognostic signature of cancer-associated fibroblasts in head and neck squamous cell carcinoma.
    Yang Y; Ma B; Han L; Xu W; Du X; Wei W; Liao T; Ji Q; Qu N; Wang Y
    Front Genet; 2022; 13():1028469. PubMed ID: 36568368
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W; Wang M; Wang M; Liu M
    Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.